Candriam S.C.A. increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 4.5% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 323,073 shares of the healthcare conglomerate’s stock after buying an additional 13,778 shares during the quarter. Candriam S.C.A.’s holdings in UnitedHealth Group were worth $119,027,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also bought and sold shares of UNH. City State Bank boosted its position in UnitedHealth Group by 5.6% during the 3rd quarter. City State Bank now owns 471 shares of the healthcare conglomerate’s stock worth $173,000 after acquiring an additional 25 shares during the last quarter. Murphy Pohlad Asset Management LLC raised its holdings in shares of UnitedHealth Group by 0.5% in the third quarter. Murphy Pohlad Asset Management LLC now owns 5,305 shares of the healthcare conglomerate’s stock valued at $1,947,000 after purchasing an additional 25 shares during the last quarter. LFG Wealth Partners LLC raised its holdings in shares of UnitedHealth Group by 3.3% in the second quarter. LFG Wealth Partners LLC now owns 853 shares of the healthcare conglomerate’s stock valued at $355,000 after purchasing an additional 27 shares during the last quarter. Synergy Financial Group LTD lifted its position in shares of UnitedHealth Group by 3.1% in the second quarter. Synergy Financial Group LTD now owns 887 shares of the healthcare conglomerate’s stock worth $369,000 after purchasing an additional 27 shares in the last quarter. Finally, Ares Financial Consulting LLC boosted its holdings in UnitedHealth Group by 7.2% during the second quarter. Ares Financial Consulting LLC now owns 419 shares of the healthcare conglomerate’s stock worth $174,000 after purchasing an additional 28 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.
Analyst Ratings Changes
UNH has been the subject of a number of analyst reports. KeyCorp reaffirmed an “overweight” rating on shares of UnitedHealth Group in a research report on Wednesday, October 14th. Bank of America restated a “buy” rating and set a $450.00 price objective on shares of UnitedHealth Group in a research note on Monday, July 20th. JPMorgan Chase & Co. raised their price objective on UnitedHealth Group from $516.00 to $524.00 and gave the company an “overweight” rating in a report on Friday, October 16th. Erste Group Bank downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, August 27th. Finally, Jefferies Financial Group upped their target price on UnitedHealth Group from $401.00 to $490.00 and gave the stock a “buy” rating in a report on Friday, July 17th. Twenty equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $463.93.
Check Out Our Latest Research Report on UNH
UnitedHealth Group Price Performance
NYSE:UNH opened at $394.14 on Friday. The stock has a market capitalization of $353.16 billion, a PE ratio of 22.51, a P/E/G ratio of 1.43 and a beta of 0.51. UnitedHealth Group Incorporated has a 1-year low of $255.96 and a 1-year high of $461.62. The firm has a fifty day simple moving average of $390.62 and a 200 day simple moving average of $364.03. The company has a current ratio of 0.74, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, beating analysts’ consensus estimates of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The firm had revenue of $112.72 billion during the quarter, compared to analysts’ expectations of $111.31 billion. During the same quarter last year, the company posted $2.59 earnings per share. The company’s revenue for the quarter was down .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, research analysts expect that UnitedHealth Group Incorporated will post 20.61 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, December 7th will be paid a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a dividend yield of 2.4%. The ex-dividend date is Monday, December 7th. UnitedHealth Group’s payout ratio is currently 53.00%.
Insider Buying and Selling at UnitedHealth Group
In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the firm’s stock in a transaction on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the sale, the chief executive officer owned 15,328 shares of the company’s stock, valued at $5,977,920. This trade represents a 7.09% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 0.19% of the company’s stock.
UnitedHealth Group News Summary
Here are the key news stories impacting UnitedHealth Group this week:
- Positive Sentiment: ETFs purchased $56.4 million of UNH shares on Nov. 4, a potentially supportive demand signal. ETFs Are Buying UnitedHealth (UNH) on Nov. 4
- Positive Sentiment: UnitedHealth’s Q3 adjusted EPS of $4.69 topped analyst expectations, and a recent earnings analysis said the results bolstered confidence in a margin recovery. UnitedHealth (UNH) Q3 Earnings Lift Confidence In Margin Recovery
- Positive Sentiment: A Zacks article characterized Wall Street analysts’ view of UNH as a Buy, offering a favorable sentiment signal, though the article summary did not cite a specific new rating change. Wall Street Analysts See UnitedHealth (UNH) as a Buy: Should You Invest?
- Positive Sentiment: The company declared a quarterly dividend of $2.32 per share, equivalent to $9.28 annually and a reported yield of 2.3%. UnitedHealth Group Declares Quarterly Dividend Of $2.32 Per Share
- Negative Sentiment: Utilization and policy concerns remain an overhang for the company, highlighting uncertainty around medical costs and the regulatory environment. Utilization and Policy Concerns Weigh on UnitedHealth Group Incorporated (UNH)
- Negative Sentiment: Renewed calls for a regulatory review of UnitedHealth’s business scale, alongside warnings that AI could disrupt large healthcare companies, add longer-term risk concerns. UnitedHealth Group (UNH) Draws Breakup Pressure As AI Threat Enters The Story
UnitedHealth Group Profile
UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid.
Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.
Founded in 1977 as United HealthCare Corporation, the company is headquartered in Minnetonka, Minnesota.
Read More
- Five stocks we like better than UnitedHealth Group
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
